Immix Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Immix Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q2 2024.
  • Immix Biopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 28.8M shares, a 91.4% increase year-over-year.
  • Immix Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 17.3M shares, a 24.9% increase from 2022.
  • Immix Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 13.9M shares, a 278% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 28.8M +13.7M +91.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 23.4M +9.54M +68.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 17.3M +3.45M +24.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 18.6M +4.65M +33.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 15M +1.16M +8.34% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 13.9M +66.8K +0.48% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 13.9M +10.2M +278% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 13.9M +10.5M +313% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 13.9M +10.5M +311% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 13.8M +10.5M +310% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 3.67M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 3.38M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 3.38M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 3.38M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.